The largest database of trusted experimental protocols

Cholestech ldx lipid monitoring system

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Cholestech LDX Lipid Monitoring System is a compact, portable device designed for the rapid measurement of lipid levels, including total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. The system utilizes a small blood sample to provide accurate and reliable lipid profile results within minutes.

Automatically generated - may contain errors

7 protocols using cholestech ldx lipid monitoring system

1

Fasted Blood Metabolic Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained under the fasted condition and glucose level was determined using a Precision QID glucometer (MediSense Inc., Bedford, MA). Serum cholesterol and triglycerides were assayed using Cholestech LDX Lipid monitoring System (Fisher Scientific, Pittsburgh PA). Serum fatty acids were determined using the EnzyChrom free fatty acid kit (BioAssay systems, Hayward, CA). Serum fasting insulin was assayed using the Ultra Sensitive Insulin ELISA Kit (Crystal Chem, Inc., Downers Grove, IL, USA). Fasting whole-body insulin sensitivity was estimated with the homeostasis model assessment of insulin resistance (HOMA-IR) according to the formula [fasting plasma glucose (mg/dL) × fasting plasma insulin (μU/mL)]/405.
+ Open protocol
+ Expand
2

Comprehensive Metabolic Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained under the fasted condition, and glucose level was determined using a Precision QID glucometer (MediSense Inc., Bedford, MA, USA). Serum cholesterol was measured using Cholestech LDX Lipid Monitoring System (Fisher Scientific, Pittsburgh, PA, USA). Serum triglycerides were measured using EnzyChrom™ Triglyceride Assay Kit (BioAssay systems, Hayward, CA, USA). Serum FFAs were determined using the EnzyChrom™ free fatty acid kit (BioAssay systems). Serum fasting insulin was assayed using the Ultra Sensitive Insulin ELISA Kit (Crystal Chem, Inc., Downers Grove, IL, USA). Fasting whole-body insulin sensitivity was estimated with the HOMA-IR according to the formula [fasting plasma glucose (mg/dL) × fasting plasma insulin (mU/mL)]/405. ALT was assayed using an ALT Assay Kit (Cayman Chemical, Ann Arbor, MI, USA).
+ Open protocol
+ Expand
3

Evaluating Metabolic Biomarkers in Fasted Subjects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained under the fasted condition and glucose level was determined using a Precision QID glucometer (MediSense Inc., Bedford, MA). Serum cholesterol and triglycerides were measured using Cholestech LDX Lipid monitoring System (Fisher Scientific, Pittsburgh PA). Serum free fatty acids (FFAs) were determined using the EnzyChrom free fatty acid kit (BioAssay systems, Hayward, CA). Serum fasting insulin was assayed using the Ultra Sensitive Insulin ELISA Kit (Crystal Chem, Inc., Downers Grove, IL). Fasting whole body insulin sensitivity was estimated with the homeostasis model assessment of insulin resistance (HOMA-IR) according to the formula [fasting plasma glucose (mg/dL) × fasting plasma insulin (μU/mL)]/405.
+ Open protocol
+ Expand
4

Fasted Blood Metabolite Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained under the fasted condition, and glucose level was determined using a Precision QID glucometer (MediSense Inc., Bedford, MA). Serum cholesterol and triglycerides were measured using Cholestech LDX Lipid monitoring System (Fisher Scientific, Pittsburgh, PA). Serum-free fatty acids (FFAs) were determined using the EnzyChrom™ free fatty acid kit (BioAssay Systems, Hayward, CA).
+ Open protocol
+ Expand
5

Comprehensive Metabolic Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained under the fasted condition and glucose level was determined using a Precision QID glucometer (MediSense Inc., Bedford, MA). Serum cholesterol and triglycerides were assayed using Cholestech LDX Lipid monitoring System (Fisher Scientific, Pittsburgh PA). Serum fatty acids were determined using the EnzyChrom FFA kit (BioAssay systems, Hayward, CA). Serum fasting insulin was assayed using the Ultra Sensitive Insulin ELISA Kit (Crystal Chem, Inc., Downers Grove, IL, USA). Fasting whole-body insulin sensitivity was estimated with the homeostasis model assessment of insulin resistance (HOMA-IR) according to the formula [fasting plasma glucose (mg/dL) x fasting plasma insulin (μU/mL)]/405. Serum alanine transaminase (ALT) was assayed using an ALT assay kit (Cayman Chemical, Ann Arbor MI).
+ Open protocol
+ Expand
6

Metabolic Markers in Fasted Condition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained under the fasted condition and glucose level was determined using a Precision QID glucometer (MediSense Inc., Bedford, MA). Serum cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglycerides were assayed using Cholestech LDX Lipid monitoring System (Fisher Scientific, Pittsburgh PA). Serum fatty acids were determined using the EnzyChrom free fatty acid kit (BioAssay systems, Hayward, CA). Serum fasting insulin was assayed using the Ultra Sensitive Insulin ELISA Kit (Crystal Chem, Inc., Downers Grove, IL, USA). Fasting whole-body insulin sensitivity was estimated with the homeostasis model assessment of insulin resistance (HOMA-IR) according to the formula [fasting plasma glucose (mg/dL) x fasting plasma insulin (μU/mL)]/405 31 (link).
+ Open protocol
+ Expand
7

Blood Metabolite Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained under the fasted condition before the euthanasia and glucose level was determined using a Precision QID glucometer (MediSense Inc., Bedford, MA). Serum cholesterol and triglycerides were measured using Cholestech LDX Lipid monitoring System (Fisher Scientific, Pittsburgh PA). Serum free fatty acids (FFAs) were determined using the EnzyChrom free fatty acid kit (BioAssay systems, Hayward, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!